Trump announces emergency authorization for treating COVID-19 patients
Category: #health  By Pankaj Singh  Date: 2020-08-25
  • share
  • Twitter
  • Facebook
  • LinkedIn

Trump announces emergency authorization for treating COVID-19 patients

U.S. President Donald Trump has reportedly announced emergency authorization for the use of convalescent plasma in the treatment of COVID-19. While Trump reportedly regarded the move to be a breakthrough, one of his top health officials described it as promising and other health experts asserted that the declaration requires more study before moving towards celebration.

The announcement follows a complaint from White House officials who stated that the Food and Drug Administration was witnessing politically motivated delays in the approval of a COVID-19 vaccine that has upended the chances of Trump’s reelection.

According to Denise Hinton, the Chief Scientist for the Food and Drug Administration, COVID-19 convalescent plasma should not be contemplated as a new benchmark of care for the treatment of COVID-19 patients. He has also stated that additional data will be coming from the ongoing clinical trials and other analyses in the ensuing months.

Even though the authorization has made it easier for some patients to receive the treatment, it is not exactly similar to full FDA approval, state sources. The blood plasma taken from patients who have recovered from the disease may deliver benefits to those struggling against COVID-19. The evidence so far has, however, not yet concluded whether it really works, when it should be administered, and what amount of dosage is required.

The pace of plasma approval had left the White House agitated, as per sources. The accusations of an FDA slowdown were presented without evidence and are cited as the recent assault from Trump’s team on what the president calls deep state bureaucracy. Mark Meadows, the White House Chief of Staff, has asserted that several people are not being as meticulous as they ought to be while getting to the bottom of the process.

The White House has sunk extensive resources into an expedited process for developing a COVID-19 vaccine. Trump advisors have been banking on it for helping the president gain ground in the upcoming elections, state sources.

 

Source Credits:

https://abcnews.go.com/Health/wireStory/trump-pushes-covid-19-treatments-claims-slowdown-fda-72555038



About Author

Pankaj Singh

Email: [email protected]   

Pankaj Singh

Pankaj Singh Develops content for Market Size Forecasters, Algosonline, and a couple of other platforms. A Post Graduate in Management by qualification, he worked as an underwriter in the UK insurance domain before deciding to switch his field of profession. With exp...

Read More

More News By Pankaj Singh

Dada Group partners with Ferrero for new snack food retail model
Dada Group partners with Ferrero for new snack food retail model
By Pankaj Singh

The new retail model will help Ferrero improve brand reach to younger online customers in China

Chinese on-demand delivery and retail platform, Dada Group has inked...

Aphena Pharma to complete expansion of Solid Dose Division by April
Aphena Pharma to complete expansion of Solid Dose Division by April
By Pankaj Singh

Aphena Pharma Solutions, a pharmaceutical services provider, has reportedly announced the continuous expansion of its Tennessee-based Solid Dose Division worth $21 million. This division is expected to be completed by ...

Canada-based CloudMD buys CMD to expand medical database
Canada-based CloudMD buys CMD to expand medical database
By Pankaj Singh

CloudMD Software & Services Inc., a virtual medical care solutions provider based in Canada, has reportedly announced that it has completed the acquisition of the Canadian Medical Directory (CMD)- the nation’...